Ove Andersen

This study tests whether a low-dose fisetin supplement (100 mg daily for 7 weeks) is safe and can reduce signs of inflammation and aging in healthy adults aged 50 and older. Researchers will compare changes in blood markers and side effects between the supplement and placebo grou…

This study follows 178 adults hospitalized with their first deep vein thrombosis (DVT) in the leg. Researchers will measure various blood markers over two years to see if they can predict long-term complications like post-thrombotic syndrome. The goal is to better understand who …

This early-stage study is testing a natural compound called fisetin in 60 healthy younger adults and older patients with multiple chronic conditions. Participants take fisetin or a placebo for two days and are followed for up to three months. The goal is to see if fisetin is safe…

This study looks at 500 older adults to find better ways to diagnose malnutrition, kidney disease, and dehydration. Researchers will compare new methods like body scans and blood tests to current standards. The goal is to make diagnosis more accurate for hospitalized and vulnerab…